Skip to main content

Weight Loss Protocol Overview

Updated over 2 weeks ago

The Maximus Weight Loss Protocol uses doctor-guided GLP-1 and GLP-1 + GIP treatments, including semaglutide and tirzepatide, to support sustainable weight loss. These medications work by influencing appetite and metabolic pathways that help regulate hunger, blood glucose, and energy balance. The protocol pairs medical treatment with ongoing clinical oversight to help you make steady, long-term progress.


How It Works (High Level)

GLP-1 and GLP-1 + GIP medications work on receptors involved in appetite and glucose regulation. Many people experience reduced hunger, improved portion control, and more stable energy throughout the day. These changes often support healthier patterns around eating, movement, and overall metabolic function.

Clinical research shows meaningful average weight-loss outcomes with GLP-1 and GLP-1 + GIP medications over time, though individual results vary. Your experience will depend on factors such as your starting point, lifestyle patterns, and how your body responds.


Who It’s For

The Weight Loss Protocol may be an option for individuals who:

  • Are looking for support in managing weight

  • Want a structured, medical approach guided by a clinician

  • Prefer FDA-approved GLP-1 or GLP-1 + GIP medications as part of their plan

  • Have goals related to metabolic health, blood glucose, or appetite regulation

Eligibility is determined by a Maximus clinician based on your health history, symptoms, and lab results.


Who It May Not Be For

Some people may be better suited to a different approach depending on their medical history or current medications. Your clinician will review your information to determine whether GLP-1 treatment is appropriate and safe for you.


Quality & Sourcing

Maximus sources the base form of semaglutide and tirzepatide from established pharmacy partners. The medications used in the protocol match the active pharmaceutical ingredient used in the well-known commercial versions. This ensures consistency with clinical research and avoids the risks associated with untested or chemically different variants.


What to Expect Over Time

Most individuals begin by noticing changes in appetite or how quickly they feel full. Weight-loss progress varies from person to person and typically builds gradually. Your clinician will monitor how you’re responding through periodic check-ins and lab evaluations, which help guide any adjustments to your treatment plan.


How Clinical Decisions Are Made

Your clinician considers:

  • Your health history

  • Lab results

  • Your goals

  • Your reported symptoms

  • How you’re responding to treatment over time

Adjustments, if appropriate, are made to ensure the protocol remains safe and aligned with your progress.


Monitoring and Follow-Up

Ongoing monitoring is an important part of safe GLP-1 treatment. Follow-up labs and check-ins help your clinician evaluate your response and make decisions about next steps. You can message your clinician through your patient portal with non-urgent questions or updates.

Did this answer your question?